TP53 and neoplasm: Therefore, to explore whether the donor EAC‐SCC tumor tissues harbored somatic mutations of TP53, and whether the established cell culture retained identical alterations, we performed WES on genomic DNA derived from the cell culture and the donor tumor tissue (from case 2) and used a patient‐matched skin tissue sample as a noncancerous control.